These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 14740273

  • 1. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
    Arkkila PE, Koskinen PJ, Kantola IM, Rönnemaa T, Seppänen E, Viikari JS.
    Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
    [Abstract] [Full Text] [Related]

  • 2. Dupuytren's disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagen.
    Arkkila PE, Koskinen PJ, Kantola IM, Rönnemaa T, Seppänen E, Viikari JS.
    Clin Exp Rheumatol; 2000 Dec; 18(2):215-9. PubMed ID: 10812494
    [Abstract] [Full Text] [Related]

  • 3. Biochemical markers of type III and I collagen: association with retinopathy and neuropathy in type 1 diabetic subjects.
    Arkkila PE, Rönnemaa T, Koskinen PJ, Kantola IM, Seppänen E, Viikari JS.
    Diabet Med; 2001 Oct; 18(10):816-21. PubMed ID: 11678972
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes.
    Arkkila PE, Kantola IM, Viikari JS, Rönnemaa T, Vähätalo MA.
    Diabet Med; 1996 Sep; 13(9):828-33. PubMed ID: 8891458
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Collagen markers in peritoneal dialysis patients.
    Graff J, Joffe P, Fugleberg S, Jensen LT.
    Adv Perit Dial; 1995 Sep; 11():24-7. PubMed ID: 8534714
    [Abstract] [Full Text] [Related]

  • 9. Bone marker alterations in patients with type 1 Gaucher disease.
    Ciana G, Martini C, Leopaldi A, Tamaro G, Katouzian F, Ronfani L, Bembi B.
    Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
    [Abstract] [Full Text] [Related]

  • 10. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
    Teppo AM, Törnroth T, Honkanen E, Grönhagen-Riska C.
    Transplantation; 2003 Jun 27; 75(12):2113-9. PubMed ID: 12829921
    [Abstract] [Full Text] [Related]

  • 11. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.
    St Clair EW, Moak SA, Wilkinson WE, Sanders L, Lang T, Greenwald RA.
    J Rheumatol; 1998 Aug 27; 25(8):1472-9. PubMed ID: 9712086
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr 27; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
    Bolarin DM, Swerdlow P, Wallace AM, Littsey L.
    Haematologia (Budap); 1998 Apr 27; 29(1):51-8. PubMed ID: 9704258
    [Abstract] [Full Text] [Related]

  • 17. Diabetic retinopathy and its association with limited joint mobility.
    Haitas B, Jones DB, Ting A, Turner RC.
    Horm Metab Res; 1986 Nov 27; 18(11):765-7. PubMed ID: 3792994
    [Abstract] [Full Text] [Related]

  • 18. [Collagen synthesis and heart failure].
    Jiménez-Navarro MF, Gómez-Doblas JJ, Cabrera-Bueno F, Cruz-Ocaña E, Rodríguez-Bailón I, Ruiz-Galdón M, Morell M, Molero E, de Teresa-Galván E.
    Rev Esp Cardiol; 2005 Aug 27; 58(8):975-8. PubMed ID: 16053832
    [Abstract] [Full Text] [Related]

  • 19. Comparison of carboxyterminal telopeptide of type I collagen (ICTP) and CA 125 as predictors of prognosis in ovarian cancer.
    Santala M, Risteli J, Kauppila A.
    Anticancer Res; 2004 Aug 27; 24(2C):1057-62. PubMed ID: 15154623
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.